Protein-based Therapeutics Market, Global Outlook and Forecast 2023-2029
Report ID
42803
Publisher
Market Monitor Global
Published Date
07-Dec
Delivery Format
PDF
No of Report Page
150
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details 
    This research report provides a comprehensive analysis of the Protein-based Therapeutics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Protein-based Therapeutics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Protein-based Therapeutics, challenges faced by the industry, and potential opportunities for market players.
The global Protein-based Therapeutics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Protein-based Therapeutics market presents opportunities for various stakeholders, including Immune Diseases, Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Protein-based Therapeutics market. Additionally, the growing consumer demand present avenues for market expansion.
The global Protein-based Therapeutics market was valued at US$ 203180 million in 2022 and is projected to reach US$ 407540 million by 2029, at a CAGR of 10.5% during the forecast period.
The Protein-based Therapeutics Market is driven by the increasing demand for innovative biopharmaceuticals that utilize proteins as therapeutic agents to treat a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. Protein-based therapies, such as monoclonal antibodies and recombinant proteins, offer highly targeted and precise treatment options. As scientific advancements and personalized medicine gain prominence, the demand for protein-based therapeutics continues to grow. Innovations in protein engineering, drug development, and manufacturing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address complex drug development processes, high production costs, and regulatory standards while ensuring accessibility and affordability for patients. Overcoming research and development challenges, optimizing drug manufacturing, and adapting to evolving healthcare regulations are ongoing hurdles. Additionally, the market faces competition from small molecules and gene-based therapies, necessitating continuous innovation to unlock the full therapeutic potential of protein-based drugs. Striking a balance between providing safe, effective, and accessible protein-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Protein-based Therapeutics Market.
Key Features:
The research report on the Protein-based Therapeutics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Protein-based Therapeutics market.
Market Overview: The report provides a comprehensive overview of the Protein-based Therapeutics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antibody-based Drugs, Fc Fusion Proteins), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Protein-based Therapeutics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Protein-based Therapeutics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Protein-based Therapeutics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
Market Segmentation and Forecast: The report segment the Protein-based Therapeutics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Protein-based Therapeutics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Protein-based Therapeutics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Protein-based Therapeutics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Protein-based Therapeutics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Protein-based Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
    Antibody-based Drugs
    Fc Fusion Proteins
    Anticoagulants
    Blood Factors
    Other
Market segment by Application
    Immune Diseases
    Cancer
    Other
Global Protein-based Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Major players covered
    AbbVie
    Johnson & Johnson
    Novartis
    Gilead Sciences
    Roche
    Bristol-Myers Squibb
    Amgen
    AstraZeneca
    Merck & Co
    Takeda
    Merck KGaA
    Seagen
    Eli Lilly
    Ono Pharmaceutical
    Pfizer
    Regeneron
    Innovent
    Hengrui Medicine
    Sanofi
    Sobi
    Kanghong Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Protein-based Therapeutics, market overview.
Chapter 2: Global Protein-based Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Protein-based Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Protein-based Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
  • Table Of Content 
    1 Introduction to Research & Analysis Reports
    1.1 Protein-based Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Protein-based Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Protein-based Therapeutics Overall Market Size
    2.1 Global Protein-based Therapeutics Market Size: 2022 VS 2029
    2.2 Global Protein-based Therapeutics Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Protein-based Therapeutics Players in Global Market
    3.2 Top Global Protein-based Therapeutics Companies Ranked by Revenue
    3.3 Global Protein-based Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Protein-based Therapeutics Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Protein-based Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Protein-based Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Protein-based Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Protein-based Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Protein-based Therapeutics Market Size Markets, 2022 & 2029
        4.1.2 Antibody-based Drugs
        4.1.3 Fc Fusion Proteins
        4.1.4 Anticoagulants
        4.1.5 Blood Factors
        4.1.6 Other
    4.2 By Type - Global Protein-based Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Protein-based Therapeutics Revenue, 2018-2023
        4.2.2 By Type - Global Protein-based Therapeutics Revenue, 2024-2029
        4.2.3 By Type - Global Protein-based Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Protein-based Therapeutics Market Size, 2022 & 2029
        5.1.2 Immune Diseases
        5.1.3 Cancer
        5.1.4 Other
    5.2 By Application - Global Protein-based Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Protein-based Therapeutics Revenue, 2018-2023
        5.2.2 By Application - Global Protein-based Therapeutics Revenue, 2024-2029
        5.2.3 By Application - Global Protein-based Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Protein-based Therapeutics Market Size, 2022 & 2029
    6.2 By Region - Global Protein-based Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Protein-based Therapeutics Revenue, 2018-2023
        6.2.2 By Region - Global Protein-based Therapeutics Revenue, 2024-2029
        6.2.3 By Region - Global Protein-based Therapeutics Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Protein-based Therapeutics Revenue, 2018-2029
        6.3.2 US Protein-based Therapeutics Market Size, 2018-2029
        6.3.3 Canada Protein-based Therapeutics Market Size, 2018-2029
        6.3.4 Mexico Protein-based Therapeutics Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Protein-based Therapeutics Revenue, 2018-2029
        6.4.2 Germany Protein-based Therapeutics Market Size, 2018-2029
        6.4.3 France Protein-based Therapeutics Market Size, 2018-2029
        6.4.4 U.K. Protein-based Therapeutics Market Size, 2018-2029
        6.4.5 Italy Protein-based Therapeutics Market Size, 2018-2029
        6.4.6 Russia Protein-based Therapeutics Market Size, 2018-2029
        6.4.7 Nordic Countries Protein-based Therapeutics Market Size, 2018-2029
        6.4.8 Benelux Protein-based Therapeutics Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Protein-based Therapeutics Revenue, 2018-2029
        6.5.2 China Protein-based Therapeutics Market Size, 2018-2029
        6.5.3 Japan Protein-based Therapeutics Market Size, 2018-2029
        6.5.4 South Korea Protein-based Therapeutics Market Size, 2018-2029
        6.5.5 Southeast Asia Protein-based Therapeutics Market Size, 2018-2029
        6.5.6 India Protein-based Therapeutics Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Protein-based Therapeutics Revenue, 2018-2029
        6.6.2 Brazil Protein-based Therapeutics Market Size, 2018-2029
        6.6.3 Argentina Protein-based Therapeutics Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Protein-based Therapeutics Revenue, 2018-2029
        6.7.2 Turkey Protein-based Therapeutics Market Size, 2018-2029
        6.7.3 Israel Protein-based Therapeutics Market Size, 2018-2029
        6.7.4 Saudi Arabia Protein-based Therapeutics Market Size, 2018-2029
        6.7.5 UAE Protein-based Therapeutics Market Size, 2018-2029
7 Protein-based Therapeutics Companies Profiles
    7.1 AbbVie
        7.1.1 AbbVie Company Summary
        7.1.2 AbbVie Business Overview
        7.1.3 AbbVie Protein-based Therapeutics Major Product Offerings
        7.1.4 AbbVie Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.1.5 AbbVie Key News & Latest Developments
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Company Summary
        7.2.2 Johnson & Johnson Business Overview
        7.2.3 Johnson & Johnson Protein-based Therapeutics Major Product Offerings
        7.2.4 Johnson & Johnson Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.2.5 Johnson & Johnson Key News & Latest Developments
    7.3 Novartis
        7.3.1 Novartis Company Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Protein-based Therapeutics Major Product Offerings
        7.3.4 Novartis Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.3.5 Novartis Key News & Latest Developments
    7.4 Gilead Sciences
        7.4.1 Gilead Sciences Company Summary
        7.4.2 Gilead Sciences Business Overview
        7.4.3 Gilead Sciences Protein-based Therapeutics Major Product Offerings
        7.4.4 Gilead Sciences Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.4.5 Gilead Sciences Key News & Latest Developments
    7.5 Roche
        7.5.1 Roche Company Summary
        7.5.2 Roche Business Overview
        7.5.3 Roche Protein-based Therapeutics Major Product Offerings
        7.5.4 Roche Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.5.5 Roche Key News & Latest Developments
    7.6 Bristol-Myers Squibb
        7.6.1 Bristol-Myers Squibb Company Summary
        7.6.2 Bristol-Myers Squibb Business Overview
        7.6.3 Bristol-Myers Squibb Protein-based Therapeutics Major Product Offerings
        7.6.4 Bristol-Myers Squibb Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.6.5 Bristol-Myers Squibb Key News & Latest Developments
    7.7 Amgen
        7.7.1 Amgen Company Summary
        7.7.2 Amgen Business Overview
        7.7.3 Amgen Protein-based Therapeutics Major Product Offerings
        7.7.4 Amgen Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.7.5 Amgen Key News & Latest Developments
    7.8 AstraZeneca
        7.8.1 AstraZeneca Company Summary
        7.8.2 AstraZeneca Business Overview
        7.8.3 AstraZeneca Protein-based Therapeutics Major Product Offerings
        7.8.4 AstraZeneca Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.8.5 AstraZeneca Key News & Latest Developments
    7.9 Merck & Co
        7.9.1 Merck & Co Company Summary
        7.9.2 Merck & Co Business Overview
        7.9.3 Merck & Co Protein-based Therapeutics Major Product Offerings
        7.9.4 Merck & Co Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.9.5 Merck & Co Key News & Latest Developments
    7.10 Takeda
        7.10.1 Takeda Company Summary
        7.10.2 Takeda Business Overview
        7.10.3 Takeda Protein-based Therapeutics Major Product Offerings
        7.10.4 Takeda Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.10.5 Takeda Key News & Latest Developments
    7.11 Merck KGaA
        7.11.1 Merck KGaA Company Summary
        7.11.2 Merck KGaA Business Overview
        7.11.3 Merck KGaA Protein-based Therapeutics Major Product Offerings
        7.11.4 Merck KGaA Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.11.5 Merck KGaA Key News & Latest Developments
    7.12 Seagen
        7.12.1 Seagen Company Summary
        7.12.2 Seagen Business Overview
        7.12.3 Seagen Protein-based Therapeutics Major Product Offerings
        7.12.4 Seagen Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.12.5 Seagen Key News & Latest Developments
    7.13 Eli Lilly
        7.13.1 Eli Lilly Company Summary
        7.13.2 Eli Lilly Business Overview
        7.13.3 Eli Lilly Protein-based Therapeutics Major Product Offerings
        7.13.4 Eli Lilly Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.13.5 Eli Lilly Key News & Latest Developments
    7.14 Ono Pharmaceutical
        7.14.1 Ono Pharmaceutical Company Summary
        7.14.2 Ono Pharmaceutical Business Overview
        7.14.3 Ono Pharmaceutical Protein-based Therapeutics Major Product Offerings
        7.14.4 Ono Pharmaceutical Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.14.5 Ono Pharmaceutical Key News & Latest Developments
    7.15 Pfizer
        7.15.1 Pfizer Company Summary
        7.15.2 Pfizer Business Overview
        7.15.3 Pfizer Protein-based Therapeutics Major Product Offerings
        7.15.4 Pfizer Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.15.5 Pfizer Key News & Latest Developments
    7.16 Regeneron
        7.16.1 Regeneron Company Summary
        7.16.2 Regeneron Business Overview
        7.16.3 Regeneron Protein-based Therapeutics Major Product Offerings
        7.16.4 Regeneron Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.16.5 Regeneron Key News & Latest Developments
    7.17 Innovent
        7.17.1 Innovent Company Summary
        7.17.2 Innovent Business Overview
        7.17.3 Innovent Protein-based Therapeutics Major Product Offerings
        7.17.4 Innovent Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.17.5 Innovent Key News & Latest Developments
    7.18 Hengrui Medicine
        7.18.1 Hengrui Medicine Company Summary
        7.18.2 Hengrui Medicine Business Overview
        7.18.3 Hengrui Medicine Protein-based Therapeutics Major Product Offerings
        7.18.4 Hengrui Medicine Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.18.5 Hengrui Medicine Key News & Latest Developments
    7.19 Sanofi
        7.19.1 Sanofi Company Summary
        7.19.2 Sanofi Business Overview
        7.19.3 Sanofi Protein-based Therapeutics Major Product Offerings
        7.19.4 Sanofi Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.19.5 Sanofi Key News & Latest Developments
    7.20 Sobi
        7.20.1 Sobi Company Summary
        7.20.2 Sobi Business Overview
        7.20.3 Sobi Protein-based Therapeutics Major Product Offerings
        7.20.4 Sobi Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.20.5 Sobi Key News & Latest Developments
    7.21 Kanghong Pharma
        7.21.1 Kanghong Pharma Company Summary
        7.21.2 Kanghong Pharma Business Overview
        7.21.3 Kanghong Pharma Protein-based Therapeutics Major Product Offerings
        7.21.4 Kanghong Pharma Protein-based Therapeutics Revenue in Global Market (2018-2023)
        7.21.5 Kanghong Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
Email: inquiry@wiredrelease.com
SHORT NAVIGATION
connect with us